← Open Payments lookup

ASAD MEHDI: Open Payments

NPI 1578779898 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,256 in 194 payments from 20 companies in 2025. Trend: 2023 $2,653 · 2024 $2,478 · 2025 $3,256

Food & beverage: $3,250Education: $5
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.29$351
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$320
ABBVIE INC.21$318
Lundbeck LLC13$311
Otsuka America Pharmaceutical, Inc.16$301
Janssen Pharmaceuticals, Inc12$207
Alkermes, Inc.9$207
Neurocrine BioSciences, Inc.11$205
Takeda Pharmaceuticals U.S.A., Inc.12$186
E.R. Squibb & Sons, L.L.C.9$178

Products named: CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, INGREZZA, UZEDY, ARISTADA, TRINTELLIX.

Industry payments across GA — which companies pay providers there.